Evidence map›Paper›PMID 39880733›Full record

ReviewThe Veterinary clinics of North America. Equine practice2025

Myosin Heavy Chain Myopathy and Immune-Mediated Muscle Disorders.

Sian A Durward-Akhurst, Stephanie J Valberg

Abstract readReview
In one paragraph

Review in The Veterinary clinics of North America. Equine practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sian A Durward-AkhurstDepartment of Veterinary Clinical Sciences, University of Minnesota, C339 VMC, 1352 Boyd Avenue, St Paul, MN 55115, USA. Electronic address: durwa004@umn.edu.
Stephanie J ValbergLarge Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI, USA.

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UM1TR004405 · NCATS · UNIVERSITY OF MINNESOTA · PI Bruce R Blazar, Damien A Fair · 2023 to 2026
$30.8M
Institutional Career Development CoreKL2TR002492 · NCATS · UNIVERSITY OF MINNESOTA · PI INGBAR, DAVID H · 2018 to 2022
$6.3M
CTSA K12 Program at University of MinnesotaK12TR004373 · NCATS · UNIVERSITY OF MINNESOTA · PI David H Ingbar · 2024 to 2026
$3.2M
NCATS NIH HHS K12 TR004373NCATS NIH HHS KL2 TR002492NCATS NIH HHS UL1 TR002494NCATS NIH HHS UM1 TR004405
6 · The paper itself

Abstract

Several inflammatory myopathies have an infectious or immune-mediated basis in the horse. Myosin heavy chain myopathy is caused by a codominant missense variant in MYH1 and has 3 clinical presentations: immune-mediated myositis, calciphylaxis, and nonexertional rhabdomyolysis in Quarter Horse-related breeds. An infarctive form of purpura hemorrhagica affects numerous breeds, presenting with focal firm, painful muscle swelling, and subsequent infarction of multiple tissues. While Streptococcus equi equi is often the inciting cause, anaplasmosis, sarcocystis, piroplasmosis, viruses, and vaccines can also be inciting agents. This article describes the diagnosis, pathophysiology, and treatment of these inflammatory myopathies.

Indexed as

Horse DiseasesMuscular DiseasesMyosin Heavy ChainsMyositisAnimalsHorsesMyosin Heavy ChainsAtrophyInfectiousInflammatoryMuscle diseaseRhabdomyolysis

Identifiers

PMID39880733
PMCPMC12614074

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.